Eidogen and Sertanty Merge | GenomeWeb

NEW YORK, March 11 (GeneWeb News) - Cheminformatics provider Sertanty and structural informatics company Eidogen -- both privately held firms -- said earlier this week that they have merged to become Eidogen-Sertanty.

Steven Muskal, founder and CEO of Sertanty, is CEO of the new company, and Derek Debe, founder and CEO of Eidogen, has assumed the role of CSO.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Ivanka Trump and Secretary of Education Betsy DeVos call on girls to pursue STEM careers, the Associated Press reports.

Some science companies will be taking part in next month's March for Science, Fortune reports.

In Genome Research this week: longitudinal study of Burkholderia cenocepacia isolates from cystic fibrosis patients, long-read assembly approach, and more.

Shale oil companies are turning to DNA sequencing to find spots to drill, Reuters reports.